Photobiomodulation (PBM) suppresses alpha-synuclein-induced toxicity in an AAV-based genetic model of Parkinson’s disease

Previous PostNear-infrared light energy penetration: Can infrared light therapy effectively reach the human brain?
Next Post810nm near-infrared light provides neuroprotection and improves motor activity in MPTP-treated mice

Disclaimer: The medical papers and academic information provided on this site are intended for educational purposes only and are not meant to diagnose, treat, prevent diseases, or substitute for a doctor’s advice.

Photobiomodulation (PBM) suppresses alpha-synuclein-induced toxicity in an AAV-based genetic model of Parkinson’s disease

Previous PostNear-infrared light energy penetration: Can infrared light therapy effectively reach the human brain?

Next Post810nm near-infrared light provides neuroprotection and improves motor activity in MPTP-treated mice

Photobiomodulation Treatment device

Hyperbaric Oxygen Chamber

Other Products

About

Learn More

Product Background

References

Get In Touch

Hyperbaric Oxygen
Chamber